Search Results

Kyverna Therapeutics, Inc. (Kyverna) announced today the publication in Proceedings of the National Academy of Sciences (PNAS)1 of a report describing the first use of KYV-101, a fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, in a 69-year-old patient suffering from treatment-refractory stiff-person syndrome (SPS) as part of a named-patient use in Germany for critically ill individuals who fail conventional therapies.

Moderna, Inc. announced that Stéphane Bancel, Chief Executive Officer, has been elected to the National Academy of Engineering, broadly known as one of the highest acknowledgments of achievement in the field, in recognition of distinguished contributions to engineering and the “development and manufacturing of pharmaceutical products, including the COVID-19 vaccine.”.

BlossomHill Therapeutics today announced Jingrong Jean Cui, Ph.D., Co-Founder, President and Chief Executive Officer of BlossomHill Therapeutics, has been elected to the National Academy of Engineering (NAE).

The Pontifical Academy of Sciences is proud to announce that Dr. Christina Rahm will be honored at its prestigious summit on May 29, 2024, at the Vatican. A distinguished scientist, entrepreneur, and philanthropist, Dr. Rahm has been recognized for her significant contributions to healthcare innovation and her unwavering commitment to improving global health.

Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.

Sonoma Biotherapeutics, Inc. announced that its Co-founder and Chief Executive Officer, Jeffrey Bluestone, Ph.D., has been elected to the National Academy of Sciences, in recognition of his groundbreaking achievements in immunology and original research.

Oct. 9, 2023 at their annual general meeting, the National Academy of Medicine announced the election of Hongkui Zeng, Ph.D, Allen Institute’s Executive Vice President and Director of the Allen Institute for Brain Science, to their membership for her leading role in understanding the cell types and the functional architecture of the mammalian brain.

Tonix Pharmaceuticals Holding Corp. announced today that Seth Lederman M.D., Chief Executive Officer of Tonix Pharmaceuticals, will present at the National Academies of Sciences, Engineering, and Medicine Committee on the Current State of Research, Development, and Stockpiling of Smallpox Medical Countermeasures public meeting on Thursday December 14, 2023.